318 related articles for article (PubMed ID: 3274444)
1. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
[No Abstract] [Full Text] [Related]
2. Effect of DR and DR6 matching on cadaver kidney transplant survival.
Reyman TA; Toledo-Pereyra LH
Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
[No Abstract] [Full Text] [Related]
3. Cyclosporine immunosuppression and perfusion preservation of cadaver kidneys.
Bradley JW; Cho SI; Cosimi AB; Monaco AP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2104-5. PubMed ID: 3079072
[No Abstract] [Full Text] [Related]
4. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
[No Abstract] [Full Text] [Related]
5. Beneficial effects of some donor-recipient HLA-DR mismatches on cadaveric graft survival: proposal for a new selection policy of recipients.
Vereerstraeten P; Andrien M; De Pauw L; Dupont E; Goldman M; Abramowicz D; Kinnaert P
Transplant Proc; 1991 Feb; 23(1 Pt 1):385-6. PubMed ID: 1990560
[No Abstract] [Full Text] [Related]
6. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
Gaber AO; Thistlethwaite JR; Haag BW; Stuart J; Mayes J; Fellner S; Stuart FP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
[No Abstract] [Full Text] [Related]
7. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
[No Abstract] [Full Text] [Related]
8. Conversion of cyclosporine to azathioprine in renal transplant patients.
Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
[No Abstract] [Full Text] [Related]
9. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
10. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
[No Abstract] [Full Text] [Related]
11. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
[No Abstract] [Full Text] [Related]
12. Monotherapy with cyclosporine in kidney transplantation.
Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
[No Abstract] [Full Text] [Related]
13. HLA-B, DR matching and cadaver renal allograft survival in New England. New England Organ Bank.
Carpenter CB; Goguen JE; Bradley JW; Turka LA; Cho SI; Milford EL
Transplant Proc; 1989 Feb; 21(1 Pt 1):663-4. PubMed ID: 2650215
[No Abstract] [Full Text] [Related]
14. Experience with 130 consecutive renal transplants in the Middle East with special reference to histocompatibility matching, antirejection therapy with antilymphocyte globulin (ALG), and prolonged preservation of imported cadaveric grafts.
Abouna GM; Kumar MS; White AG; Daddah S; John P; Samhan M; Omar OF; Kusma G
Transplant Proc; 1984 Aug; 16(4):1114-7. PubMed ID: 6380057
[No Abstract] [Full Text] [Related]
15. Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
Friend PJ; Calne RY; Hale G; Waldmann H; Evans DB; Rolles K; Thiru S; Gore S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1898-900. PubMed ID: 3079058
[No Abstract] [Full Text] [Related]
16. The benefits of HLA matching on renal transplantation relative to cyclosporine use and organ sharing.
Sanfilippo F; Vaughn WK; LeFor WM; Alexander JW; Pfaff WW
Transplant Proc; 1989 Feb; 21(1 Pt 1):661-2. PubMed ID: 2650214
[No Abstract] [Full Text] [Related]
17. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
Ono Y; Ohshima S; Fujita T; Kinukawa T; Matsuura O; Hirabayashi S; Takeuchi N
Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
[No Abstract] [Full Text] [Related]
18. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
Muñoz C; Franco A; Prados MC; de la Sen ML; Perdiguero M; Olivares J
Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
[No Abstract] [Full Text] [Related]
19. Repeated DR mismatching need not be hazardous to kidney graft survival.
Salmela K; Eklund B; Höckerstedt K; Isoniemi H; Koskimies S; von Willebrand E; Ahonen J
Transplant Proc; 1989 Feb; 21(1 Pt 1):677-8. PubMed ID: 2650219
[No Abstract] [Full Text] [Related]
20. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
Chen M; Wade J; Levy GA; Greig PD
Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
